High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group

Introduction. Osteosarcoma relapse has a poor prognosis, with less than 25% survival at 5 years. We describe the experience of the French Society of Paediatric Oncology (SFCE) with high dose (HD) thiotepa and autologous stem cell transplantation (ASCT) in 45 children with relapsed osteosarcoma. Pati...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Marec-Berard, Perrine, Segura-Ferlay, Céline, Tabone, Marie-Dominique, Pacquement, Helene, Lervat, Cyril, Gentet, Jean-Claude, Schmitt, Claudine, Gaspar, Nathalie, Brugières, Laurence
格式: Artigo
語言:Inglês
出版: Hindawi Publishing Corporation 2014
主題:
Clinical Study
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3941142/
https://ncbi.nlm.nih.gov/pubmed/24672280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/475067
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍